Cargando…
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
Recent emergence of SARS-CoV-1 variants demonstrates the potential of this virus for targeted evolution, despite its overall genomic stability. Here we show the dynamics and the mechanisms behind the rapid adaptation of SARS-CoV-2 to growth in Vero E6 cells. The selective advantage for growth in Ver...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906416/ https://www.ncbi.nlm.nih.gov/pubmed/35019723 http://dx.doi.org/10.1128/jvi.02186-21 |
_version_ | 1784665399628922880 |
---|---|
author | Chaudhry, M. Zeeshan Eschke, Kathrin Hoffmann, Markus Grashoff, Martina Abassi, Leila Kim, Yeonsu Brunotte, Linda Ludwig, Stephan Kröger, Andrea Klawonn, Frank Pöhlmann, Stefan H. Cicin-Sain, Luka |
author_facet | Chaudhry, M. Zeeshan Eschke, Kathrin Hoffmann, Markus Grashoff, Martina Abassi, Leila Kim, Yeonsu Brunotte, Linda Ludwig, Stephan Kröger, Andrea Klawonn, Frank Pöhlmann, Stefan H. Cicin-Sain, Luka |
author_sort | Chaudhry, M. Zeeshan |
collection | PubMed |
description | Recent emergence of SARS-CoV-1 variants demonstrates the potential of this virus for targeted evolution, despite its overall genomic stability. Here we show the dynamics and the mechanisms behind the rapid adaptation of SARS-CoV-2 to growth in Vero E6 cells. The selective advantage for growth in Vero E6 cells is due to increased cleavage efficiency by cathepsins at the mutated S1/S2 site. S1/S2 site also constitutes a heparan sulfate (HS) binding motif that influenced virus growth in Vero E6 cells, but HS antagonist did not inhibit virus adaptation in these cells. The entry of Vero E6-adapted virus into human cells is defective because the mutated spike variants are poorly processed by furin or TMPRSS2. Minor subpopulation that lack the furin cleavage motif in the spike protein rapidly become dominant upon passaging through Vero E6 cells, but wild type sequences are maintained at low percentage in the virus swarm and mediate a rapid reverse adaptation if the virus is passaged again on TMPRSS2(+) human cells. Our data show that the spike protein of SARS-CoV-2 can rapidly adapt itself to available proteases and argue for deep sequence surveillance to identify the emergence of novel variants. IMPORTANCE Recently emerging SARS-CoV-2 variants B.1.1.7 (alpha variant), B.1.617.2 (delta variant), and B.1.1.529 (omicron variant) harbor spike mutations and have been linked to increased virus pathogenesis. The emergence of these novel variants highlights coronavirus adaptation and evolution potential, despite the stable consensus genotype of clinical isolates. We show that subdominant variants maintained in the virus population enable the virus to rapidly adapt to selection pressure. Although these adaptations lead to genotype change, the change is not absolute and genomes with original genotype are maintained in the virus swarm. Thus, our results imply that the relative stability of SARS-CoV-2 in numerous independent clinical isolates belies its potential for rapid adaptation to new conditions. |
format | Online Article Text |
id | pubmed-8906416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-89064162022-03-10 Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases Chaudhry, M. Zeeshan Eschke, Kathrin Hoffmann, Markus Grashoff, Martina Abassi, Leila Kim, Yeonsu Brunotte, Linda Ludwig, Stephan Kröger, Andrea Klawonn, Frank Pöhlmann, Stefan H. Cicin-Sain, Luka J Virol Genetic Diversity and Evolution Recent emergence of SARS-CoV-1 variants demonstrates the potential of this virus for targeted evolution, despite its overall genomic stability. Here we show the dynamics and the mechanisms behind the rapid adaptation of SARS-CoV-2 to growth in Vero E6 cells. The selective advantage for growth in Vero E6 cells is due to increased cleavage efficiency by cathepsins at the mutated S1/S2 site. S1/S2 site also constitutes a heparan sulfate (HS) binding motif that influenced virus growth in Vero E6 cells, but HS antagonist did not inhibit virus adaptation in these cells. The entry of Vero E6-adapted virus into human cells is defective because the mutated spike variants are poorly processed by furin or TMPRSS2. Minor subpopulation that lack the furin cleavage motif in the spike protein rapidly become dominant upon passaging through Vero E6 cells, but wild type sequences are maintained at low percentage in the virus swarm and mediate a rapid reverse adaptation if the virus is passaged again on TMPRSS2(+) human cells. Our data show that the spike protein of SARS-CoV-2 can rapidly adapt itself to available proteases and argue for deep sequence surveillance to identify the emergence of novel variants. IMPORTANCE Recently emerging SARS-CoV-2 variants B.1.1.7 (alpha variant), B.1.617.2 (delta variant), and B.1.1.529 (omicron variant) harbor spike mutations and have been linked to increased virus pathogenesis. The emergence of these novel variants highlights coronavirus adaptation and evolution potential, despite the stable consensus genotype of clinical isolates. We show that subdominant variants maintained in the virus population enable the virus to rapidly adapt to selection pressure. Although these adaptations lead to genotype change, the change is not absolute and genomes with original genotype are maintained in the virus swarm. Thus, our results imply that the relative stability of SARS-CoV-2 in numerous independent clinical isolates belies its potential for rapid adaptation to new conditions. American Society for Microbiology 2022-03-09 /pmc/articles/PMC8906416/ /pubmed/35019723 http://dx.doi.org/10.1128/jvi.02186-21 Text en Copyright © 2022 American Society for Microbiology. https://doi.org/10.1128/ASMCopyrightv2All Rights Reserved (https://doi.org/10.1128/ASMCopyrightv2) . https://doi.org/10.1128/ASMCopyrightv2This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Genetic Diversity and Evolution Chaudhry, M. Zeeshan Eschke, Kathrin Hoffmann, Markus Grashoff, Martina Abassi, Leila Kim, Yeonsu Brunotte, Linda Ludwig, Stephan Kröger, Andrea Klawonn, Frank Pöhlmann, Stefan H. Cicin-Sain, Luka Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases |
title | Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases |
title_full | Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases |
title_fullStr | Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases |
title_full_unstemmed | Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases |
title_short | Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases |
title_sort | rapid sars-cov-2 adaptation to available cellular proteases |
topic | Genetic Diversity and Evolution |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906416/ https://www.ncbi.nlm.nih.gov/pubmed/35019723 http://dx.doi.org/10.1128/jvi.02186-21 |
work_keys_str_mv | AT chaudhrymzeeshan rapidsarscov2adaptationtoavailablecellularproteases AT eschkekathrin rapidsarscov2adaptationtoavailablecellularproteases AT hoffmannmarkus rapidsarscov2adaptationtoavailablecellularproteases AT grashoffmartina rapidsarscov2adaptationtoavailablecellularproteases AT abassileila rapidsarscov2adaptationtoavailablecellularproteases AT kimyeonsu rapidsarscov2adaptationtoavailablecellularproteases AT brunottelinda rapidsarscov2adaptationtoavailablecellularproteases AT ludwigstephan rapidsarscov2adaptationtoavailablecellularproteases AT krogerandrea rapidsarscov2adaptationtoavailablecellularproteases AT klawonnfrank rapidsarscov2adaptationtoavailablecellularproteases AT pohlmannstefanh rapidsarscov2adaptationtoavailablecellularproteases AT cicinsainluka rapidsarscov2adaptationtoavailablecellularproteases |